Clinical trials: Chemotherapy-Induced Peripheral Neuropathy
- Condition Chemotherapy-Induced Peripheral Neuropathy
- Funder type Industry (pharma, biotech, devices)
- Age group Children (under 18)
Peripheral Sensory Neuropathy
Clinical Study on Acetyl-L-Carnitine
Chemotherapy-induced peripheral neuropathy (CIPN) is a common clinical dose-limiting adverse drug reaction, and the primary manifestations are different degree of neuromotor, sensorineural and autonomic nervous dysfunction.
- Trial name
- NCT01526564
- Testing
- Acetylcarnitine
- Volunteers
- 239 people
- Sponsor
- Lee's Pharmaceutical Limited